• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Developing Bdellovibrio as Living Antibiotics

The bacteria Bdellovibrio -- harmless to humans -- naturally kill a wide range of gram-negative pathogens which are known to cause many infections. Professor Liz Sockett of the University of Nottingham in England will study whether these pathogens have the ability to form resistance to Bdellovibrio, and if Bdellovibrio can be delivered to patients as a living antibiotic.

More information about Create Drugs and Delivery Systems to Limit Drug Resistance (Round 1)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.